Activating mutations in ALK provide a therapeutic target in neuroblastoma
Harvard University · Dana-Farber Cancer Institute · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
892
total citations
- FWCI
- 39.07
- Percentile
- 100%
- References
- 26
Citations per year
Authors
21Topics & keywords
Topics
Keywords
- Neuroblastoma
- Anaplastic lymphoma kinase
- Cancer research
- Biology
- Gene knockdown
- Molecular biology
- Small hairpin RNA
- Mutation
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.